These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 17177272)

  • 1. Interval estimation of the risk difference in non-compliance randomized trials with repeated binary measurements.
    Lui KJ
    Stat Med; 2007 Jul; 26(16):3140-56. PubMed ID: 17177272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interval estimation of risk ratio in the simple compliance randomized trial.
    Lui KJ
    Contemp Clin Trials; 2007 Feb; 28(2):120-9. PubMed ID: 16820329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimation of the risk difference under a noncompliance randomized clinical trial with missing outcomes.
    Lui KJ
    J Biopharm Stat; 2008; 18(2):273-92. PubMed ID: 18327721
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Five interval estimators for proportion ratio under a stratified randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    Biom J; 2007 Aug; 49(4):613-26. PubMed ID: 17634977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five interval estimators of the risk difference under stratified randomized clinical trials with noncompliance and repeated measurements.
    Lui KJ; Chang KC
    J Biopharm Stat; 2013; 23(4):756-73. PubMed ID: 23786643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interval estimation of the proportion ratio in repeated binary measurements under a stratified randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2012; 22(1):109-32. PubMed ID: 22204530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Eight interval estimators of a common rate ratio under stratified Poisson sampling.
    Lui KJ
    Stat Med; 2004 Apr; 23(8):1283-96. PubMed ID: 15083483
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interval estimation of the proportion ratio under multiple matching.
    Lui KJ
    Stat Med; 2005 Apr; 24(8):1275-85. PubMed ID: 15565736
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interval estimation of generalized odds ratio in data with repeated measurements.
    Lui KJ
    Stat Med; 2002 Oct; 21(20):3107-17. PubMed ID: 12369085
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size determination for assessing equivalence based on proportion ratio under a randomized trial with non-compliance and missing outcomes.
    Lui KJ; Chang KC
    Stat Med; 2008 Jan; 27(1):47-67. PubMed ID: 17708514
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Test equality and sample size calculation based on risk difference in a randomized clinical trial with noncompliance and missing outcomes.
    Lui KJ; Chang KC
    Biom J; 2008 Apr; 50(2):224-36. PubMed ID: 18264992
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interval estimation of the difference in proportions under m-to-one matching.
    Lui KJ
    Stat Med; 2005 Jun; 24(11):1765-76. PubMed ID: 15736281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Notes on interval estimation of the attributable risk in cross-sectional sampling.
    Lui KJ
    Stat Med; 2001 Jun; 20(12):1797-809. PubMed ID: 11406842
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interval estimation of the attributable risk for multiple exposure levels in case-control studies with confounders.
    Lui KJ
    Stat Med; 2003 Aug; 22(15):2443-57. PubMed ID: 12872301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Test homogeneity of odds ratio in a randomized clinical trial with noncompliance.
    Lui KJ; Chang KC
    J Biopharm Stat; 2009 Sep; 19(5):916-32. PubMed ID: 20183452
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimation of attributable risk for case-control studies with multiple matching.
    Lui KJ
    Stat Med; 2005 Oct; 24(19):2953-62. PubMed ID: 16149122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Covariate adjustment in clinical trials with non-ignorable missing data and non-compliance.
    Levy DE; O'Malley AJ; Normand SL
    Stat Med; 2004 Aug; 23(15):2319-39. PubMed ID: 15273951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. On estimating treatment effects under non-compliance in randomized clinical trials: are intent-to-treat or instrumental variables analyses perfect solutions?
    Bang H; Davis CE
    Stat Med; 2007 Feb; 26(5):954-64. PubMed ID: 16900559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple imputation methods for treatment noncompliance and nonresponse in randomized clinical trials.
    Taylor L; Zhou XH
    Biometrics; 2009 Mar; 65(1):88-95. PubMed ID: 18397338
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Testing homogeneity of the risk ratio in stratified noncompliance randomized trials.
    Lui KJ
    Contemp Clin Trials; 2007 Sep; 28(5):614-25. PubMed ID: 17409026
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.